BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25818795)

  • 1. [Effects of α1-PDX, a furin inhibitor, on growth, invasion, and tumorigenicity of cervical cancer HeLa cells].
    Shi C; Zhang G; Han B; Yang J; Liu H; Xi J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):432-6. PubMed ID: 25818795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.
    Bassi DE; Lopez De Cicco R; Mahloogi H; Zucker S; Thomas G; Klein-Szanto AJ
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10326-31. PubMed ID: 11517338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of PDX in regulating cervical cancer HeLa cell proliferation and tumor formation.
    Chen Y; Li DJ; Wu TT; Ruan HB; Zheng MY
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6268-6273. PubMed ID: 30338795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness.
    Mercapide J; Lopez De Cicco R; Bassi DE; Castresana JS; Thomas G; Klein-Szanto AJP
    Clin Cancer Res; 2002 Jun; 8(6):1740-6. PubMed ID: 12060611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A furin inhibitor downregulates osteosarcoma cell migration by downregulating the expression levels of MT1-MMP via the Wnt signaling pathway.
    Liu B; Li G; Wang X; Liu Y
    Oncol Lett; 2014 Apr; 7(4):1033-1038. PubMed ID: 24944664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.
    Jean F; Stella K; Thomas L; Liu G; Xiang Y; Reason AJ; Thomas G
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7293-8. PubMed ID: 9636142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of shRNA targeting GPR48 on invasion and metastasis of human cervical carcinoma cell line HeLa.
    Gao Y; Shan ZY; Wang H; Zhang HM; Teng WP
    Ai Zheng; 2009 Feb; 28(2):104-7. PubMed ID: 19550120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of furin-like proprotein convertases in the arterial response to injury.
    Sluijter JP; Verloop RE; Pulskens WP; Velema E; Grimbergen JM; Quax PH; Goumans MJ; Pasterkamp G; de Kleijn DP
    Cardiovasc Res; 2005 Oct; 68(1):136-43. PubMed ID: 15963479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development.
    Cui Y; Jean F; Thomas G; Christian JL
    EMBO J; 1998 Aug; 17(16):4735-43. PubMed ID: 9707432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions.
    Khatib AM; Siegfried G; Prat A; Luis J; Chrétien M; Metrakos P; Seidah NG
    J Biol Chem; 2001 Aug; 276(33):30686-93. PubMed ID: 11402025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect and mechanism of an autophagy gene beclin 1 on cervical cancer HeLa cells].
    Wang ZH; Li L; Duan ZL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):125-31. PubMed ID: 21426771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.
    Hada K; Isshiki K; Matsuda S; Yuasa K; Tsuji A
    Protein Eng Des Sel; 2013 Feb; 26(2):123-31. PubMed ID: 23155057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating furin activity with designed mini-PDX peptides: synthesis and in vitro kinetic evaluation.
    Basak A; Lotfipour F
    FEBS Lett; 2005 Aug; 579(21):4813-21. PubMed ID: 16102752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant.
    Anderson ED; Thomas L; Hayflick JS; Thomas G
    J Biol Chem; 1993 Nov; 268(33):24887-91. PubMed ID: 8227051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
    Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
    Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
    Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
    Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
    Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of systemic furin in immune response-induced arthritis.
    Lin H; Ah Kioon MD; Lalou C; Larghero J; Launay JM; Khatib AM; Cohen-Solal M
    Arthritis Rheum; 2012 Sep; 64(9):2878-86. PubMed ID: 22605541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy-associated Furin Expression and Tumor Invasiveness in Recurrent Laryngeal Cancer.
    Lee M; Ryu CH; Chang HW; Kim GC; Kim SW; Kim SY
    Anticancer Res; 2016 Oct; 36(10):5117-5125. PubMed ID: 27798871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.